September 16, 2014 10:53 AM ET

Healthcare Equipment and Supplies

Company Overview of Banyan Biomarkers, Inc.

Company Overview

Banyan Biomarkers, Inc. researches and develops in vitro diagnostic products to detect traumatic brain injuries (TBIs). The company offers biomarkers for traumatic brain injuries and strokes, psychiatric disorders, neuroinflammation/microglial activation, apoptosis, necrosis, and liver injuries/hepatoxicity; biomarkers for stroke, Alzheimer’s disease, Parkinson’s and Huntington’s disease, and depression; and therapeutic candidates for neuro-protection. It also develops sandwich-enzyme linked immunosorbent assays in cerebro-spinal fluid, plasma, and serum for various neurological, neurodegenerative, and neuropsychiatric diseases. In addition, the company offers preclinical and clinical sample...

13400 Progress Boulevard

Alachua, FL 32615

United States

Founded in 2002

Phone:

386-462-6699

Fax:

386-418-2184

Key Executives for Banyan Biomarkers, Inc.

Chief Executive Officer
Executive Chairman
Age: 72
Founder and Director
Director of Corporate Operations
Compensation as of Fiscal Year 2014.

Banyan Biomarkers, Inc. Key Developments

Banyan Biomarkers, Inc. Presents at Latin America & Caribbean Life Sciences Conference, Mar-28-2014 10:45 AM

Banyan Biomarkers, Inc. Presents at Latin America & Caribbean Life Sciences Conference, Mar-28-2014 10:45 AM. Venue: Graham Center Ballroom, FIU-Maidique Campus, Miami, Florida, United States. Speakers: Luis De Taboada, Vice President of Engineering.

Banyan Biomarkers, Inc. Presents at Southeast BIO Investor & Partnering Forum, Nov-06-2013 02:05 PM

Banyan Biomarkers, Inc. Presents at Southeast BIO Investor & Partnering Forum, Nov-06-2013 02:05 PM. Venue: Jefferson Hotel, Richmond, Virginia, United States.

Banyan Biomarkers, Inc. Wins $12,950,816 Cost-Plus-Fixed-Fee, Non-Option-Eligible, Multi-Year Contract

Banyan Biomarkers Inc. was awarded a $12,950,816 cost-plus-fixed-fee, non-option-eligible, multi-year contract modification (P00015) of contract (W81XWH-10-C-0251) for a within scope increase to develop a mild/moderate traumatic brain injury assay for use on the Johnson & Johnson/Ortho Clinical Diagnostics VITROs (r) MicroWell device to analyze clinical trial samples. Performance locations will be Rochester, N.Y., Alachua, Fla., and Carlsbad, Calif., with funding from fiscal 2012 and 2013 research development testing and evaluation funds. This contract was a non- competitive acquisition with one bid received. The U.S. Army Medical Research Acquisition Activity, Frederick, Md., is the contracting activity.

Similar Private Companies By Industry

Company Name Region
Prolab Sales, Inc. United States
FEL Shares, Inc. United States
Extremity Medical, LLC United States
Hart Specialties Inc. United States
Inteprod LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 3, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Banyan Biomarkers, Inc., please visit www.banyanbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.